• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Vasectomy Market Size

    ID: MRFR/MED/3282-HCR
    110 Pages
    Rahul Gotadki
    October 2025

    Vasectomy Market Research Report Information By Type (Conventional Vasectomy, No-Scalpel Vasectomy, Minimally Invasive Vasectomy), Drug (Anesthetics, Painkillers, Antibiotics), Patient (Humans, Animals), End User (Hospitals And Clinics) - Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Vasectomy Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Vasectomy Size

    Vasectomy Market Growth Projections and Opportunities

    Males increasingly choose vasectomy for permanent contraception. Its efficiency, convenience of use, and one-time operation have made it popular. The widespread use of vasectomy as birth control also keeps the market stable. Vasectomy is a long-term contraceptive procedure, thus demand is steady. Urologists and healthcare providers that perform vasectomy treatments have a continuous patient base of males seeking permanent contraception. The market is heavily influenced by vasectomy reimbursement. Favorable payment standards may motivate healthcare practitioners to perform vasectomy and urge patients to undergo the procedure. Cultural and social ideas on family planning and contraception affect the vasectomy market. Cultural norms, awareness efforts, and education may affect vasectomy acceptance and usage as birth control. Urologists and other medical experts' competence is crucial to vasectomy surgeries. Skilled professionals who can counsel patients, provide therapy, and resolve problems affect the market. Public awareness and education initiatives on vasectomy may affect the market. More information about the therapy, its safety, and its benefits may increase acceptability and commercial potential. Vasectomy surgical procedures and technology might affect market dynamics. Advances in vasectomy efficacy, safety, and recovery may encourage more people to undertake the therapy. The availability and effectiveness of condoms, intrauterine devices (IUDs), and oral contraceptives may affect the vasectomy industry. Competition from other birth control techniques may impact vasectomy rates. Vasectomy legislation and standards may affect the market. Clear legislation and regulated practices may boost public faith in vasectomy as a safe and controlled procedure while benefiting healthcare providers. Cost and socioeconomic accessibility of vasectomy may affect market dynamics. Potential patients may be influenced by pricing and the availability of subsidized or low-cost vasectomy procedures. Psychological factors including fear, misunderstanding, and vasectomy stigma may affect business growth. Education and counseling may reduce these barriers and make the market more receptive. Demographic factors like age distribution and family size may affect the vasectomy market. Social opinions on family planning and expected family sizes may affect demand for permanent contraceptives like vasectomy.

    Vasectomy Market Size Graph

    Market Summary

    As per Market Research Future Analysis, the global vasectomy market is projected to grow at a CAGR of 7.4%, reaching a value of USD 27.46 billion from 2023 to 2032. Vasectomy is a permanent male sterilization procedure that effectively prevents pregnancy by cutting and sealing the vas deferens. The procedure is minimally invasive, typically completed in under 30 minutes, and allows patients to resume normal sexual activity within a week. The market is driven by increasing global population, hormonal disturbances, and rising gender equality, while challenges include the impact of COVID-19 on production and supply chains. The market is segmented by type, drugs, end-users, patients, and regions, with North America holding the largest market share due to high demand and advanced medical infrastructure.

    Key Market Trends & Highlights

    Key trends influencing the vasectomy market include technological advancements and changing societal attitudes towards male contraception.

    • Market expected to grow at a CAGR of 7.4% from 2023 to 2032.
    • North America holds the largest market share due to gender equality and healthcare demand.
    • COVID-19 pandemic significantly impacted production and supply chains.
    • Emerging technologies are creating new opportunities in the vasectomy market.

    Market Size & Forecast

    Market Size USD 27.46 Billion by 2032
    CAGR 7.4%
    Largest Regional Market North America
    Market Segmentation By Type, Drugs, End-User, Patients, Region.

    Major Players

    Key players include Pfizer Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company Inc., Accurate Surgical & Scientific Instruments Corporation, and Sklar Surgical Instruments.

    Market Trends

    The increasing acceptance of vasectomy as a reliable form of contraception reflects a broader trend towards informed reproductive choices among men, suggesting a shift in societal attitudes towards male sterilization procedures.

    U.S. Centers for Disease Control and Prevention (CDC)

    Vasectomy Market Market Drivers

    Market Growth Projections

    The Global Vasectomy Market Industry is projected to experience substantial growth in the coming years. With a current valuation of 16.8 USD Billion in 2024, the market is anticipated to reach 34.0 USD Billion by 2035. This represents a significant increase, driven by various factors including rising awareness of family planning, technological advancements, and changing societal attitudes towards male contraception. The expected compound annual growth rate (CAGR) of 6.63% from 2025 to 2035 further underscores the potential for expansion within this sector. These projections indicate a robust future for the vasectomy market as it adapts to evolving consumer needs and preferences.

    Government Initiatives and Support

    Government initiatives and support play a crucial role in shaping the Global Vasectomy Market Industry. Many countries have implemented policies aimed at promoting family planning and reproductive health services, which include vasectomy. These initiatives often provide funding for educational programs and subsidized healthcare services, making vasectomy more accessible to the public. For instance, countries with robust family planning programs report higher rates of vasectomy acceptance. This governmental backing not only raises awareness but also encourages men to consider vasectomy as a responsible choice, contributing to the projected CAGR of 6.63% for the period from 2025 to 2035.

    Rising Awareness of Family Planning

    The increasing awareness surrounding family planning and reproductive health is a pivotal driver for the Global Vasectomy Market Industry. Educational campaigns and healthcare initiatives have emphasized the importance of responsible parenthood, leading to a growing acceptance of vasectomy as a viable option for permanent contraception. This trend is particularly evident in developed nations, where the demand for vasectomies is on the rise. As of 2024, the Global Vasectomy Market is valued at 16.8 USD Billion, reflecting a shift in societal attitudes towards male sterilization. This awareness is expected to further bolster market growth as more individuals consider vasectomy as a practical solution.

    Changing Attitudes Towards Male Contraception

    Changing attitudes towards male contraception are reshaping the Global Vasectomy Market Industry. Traditionally, contraceptive responsibility has been predominantly placed on women, but there is a noticeable shift as men increasingly recognize the importance of sharing this responsibility. This evolving mindset is fostering a more open dialogue about male sterilization options, including vasectomy. As societal norms continue to evolve, more men are likely to consider vasectomy as a practical and responsible choice. This cultural shift is expected to drive market growth, aligning with the overall trend of increasing acceptance of male contraceptive methods.

    Technological Advancements in Surgical Techniques

    Technological advancements in surgical techniques are significantly influencing the Global Vasectomy Market Industry. Innovations such as no-scalpel vasectomy and advanced anesthesia methods have improved patient experiences and outcomes, leading to increased adoption rates. These minimally invasive procedures reduce recovery times and complications, making vasectomy a more appealing option for men. As healthcare providers adopt these modern techniques, the market is likely to witness a surge in demand. The anticipated growth trajectory suggests that by 2035, the market could reach 34.0 USD Billion, driven by these advancements that enhance the overall efficacy and safety of the procedure.

    Increased Healthcare Access and Insurance Coverage

    Increased healthcare access and insurance coverage are significant factors driving the Global Vasectomy Market Industry. As healthcare systems evolve, more individuals gain access to reproductive health services, including vasectomy. Insurance providers are increasingly covering the costs associated with the procedure, reducing financial barriers for potential patients. This trend is particularly pronounced in regions where healthcare reforms have expanded coverage for family planning services. As a result, more men are likely to opt for vasectomy, contributing to the market's growth trajectory. The combination of improved access and financial support is expected to enhance the overall adoption rates of vasectomy.

    Market Segment Insights

    Regional Insights

    Key Companies in the Vasectomy Market market include

    Industry Developments

    Pfizer Inc. and BioNTech S.E. today announced that they had submitted an application to the U.S. Food and Drug Administration for emergency use authorization of an additional booster dose for the adults. The submission is completely based on the two-real world data sets from Israel.

    Future Outlook

    Vasectomy Market Future Outlook

    The Global Vasectomy Market is projected to grow at a 6.63% CAGR from 2024 to 2035, driven by rising awareness, technological advancements, and increasing demand for permanent contraception.

    New opportunities lie in:

    • Develop innovative minimally invasive vasectomy techniques to enhance patient comfort and recovery.
    • Expand telehealth services for pre- and post-operative consultations to improve accessibility.
    • Invest in educational campaigns targeting younger demographics to increase awareness and acceptance of vasectomy.

    By 2035, the Vasectomy Market is expected to demonstrate robust growth, reflecting evolving societal attitudes towards family planning.

    Market Segmentation

    Vasectomy Market Segmentation

    By Type
    • Conventional Vasectomy
    • No-scalpel Vasectomy
    • Minimally Invasive Vasectomy
    By Drugs
    • Anesthetics
    • Painkillers
    • Antibiotics
    • Others
    By End-User
    • Hospital & Clinics
    • Research and academics
    • Others
    By Patients
    • Human
    • Animals
    By Regional Sectors
    • Asia-Pacific
    • Europe
    • South America
    • North America
    • Middle East & Africa
    Some of the key market players are
    • {"Pfizer Inc."=>[]}
    • Abbott
    • GlaxoSmithKline plc.
    • Sanofi S.A.
    • Novartis AG
    • Bayer AG
    • Bristol Myers Squibb Company
    • Eli Lilly and Company Inc.
    • Accurate Surgical & Scientific Instruments Corporation
    • Sklar Surgical Instruments

    Report Scope

    Attribute/Metric Details
    Market Size 2022 N/A (USD Billion)
    Market Size 2023 N/A (USD Billion)
    Market Size 2032 27.46 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.4 % (2024- 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2022
    Market Forecast Period 2023 - 2032
    Historical Data 2019 - 2022
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Inc., Accurate Surgical & Scientific Instruments Corporation, Sklar Surgical Instruments, Advanced Meditech International and others
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers Rising demand due to growing population Increasing male-female equality Side effects of female contraception

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. Table Of Content
    2. Report Prologue
    3. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. Market Dynamics
      1. Drivers
      2. Restrains
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Technology Trends & Assessment
    6. Market Factor Analysis
      1. Porters Five Forces Analysis
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    7. Global Vasectomy Market, By Type
      1. Introduction
      2. Conventional Vasectomy
        1. Market Estimates & Forecast, 2023-2030
      3. No-Scalpel Vasectomy
        1. Market Estimates & Forecast, 2023-2030
      4. Minimally Invasive Vasectomy
        1. Market Estimates & Forecast, 2023-2030
    8. Global Vasectomy Market, By Drugs
      1. Introduction
      2. Anesthetics
        1. Market Estimates & Forecast, 2023-2030
      3. Pain Killers
        1. Market Estimates & Forecast, 2023-2030
      4. Antibiotics
        1. Market Estimates & Forecast, 2023-2030
      5. Others
        1. Market Estimates & Forecast, 2023-2030
    9. Global Vasectomy Market, By Patients
      1. Introduction
      2. Humans
        1. Market Estimates & Forecast, 2023-2030
      3. Animals
        1. Market Estimates & Forecast, 2023-2030
    10. Global Vasectomy Market, By End-User
      1. Introduction
      2. Hospitals And Clinics
        1. Market Estimates & Forecast, 2023-2030
      3. Research And Academics
        1. Market Estimates & Forecast, 2023-2030
      4. Others
        1. Market Estimates & Forecast, 2023-2030
    11. Global Vasectomy Market, By Region
      1. Introduction
      2. Americas
        1. North America
        2. South America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic Of Korea
        6. Rest Of Asia Pacific
      5. The Middle East & Africa
        1. United Arab Emirates
        2. Saudi Arabia
        3. Oman
        4. Kuwait
        5. Qatar
        6. Rest Of The Middle East & Africa
    12. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
    13. Company Profiles
      1. Pfizer, Inc.
        1. Overview
        2. Product Overview
        3. Financials
        4. Key GlaxoSmithKline Plc
        5. Overview
        6. Product Overview
        7. Financials
        8. Key Developments
      2. Sanofi S.A.
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      3. Accurate Surgical & Scientific Instruments Corporation
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      4. Sklar Surgical Instruments
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      5. Novartis AG
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      6. Abbott
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      7. Advanced Meditech International
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      8. Others
    14. MRFR Conclusion
      1. Key Findings
        1. From CEO’s View Point
        2. Unmet Needs Of The Market
      2. Key Companies To Watch
      3. Prediction Of Vasectomy Industry
    15. Appendix
    16. List of Tables and Figures
      1. List Of Tables
      2. TABLE 1 GLOBAL VASECTOMY MARKET, BY TYPE, 2023-2030 (USD MILLION)
      3. TABLE 2 ASEPTIC ISOLATORS FOR VASECTOMY MARKET, BY REGION, 2023-2030 (USD MILLION)
      4. TABLE 3 CONVENTIONAL VASECTOMY FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      5. TABLE 4 NO-SCALPEL VASECTOMY FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      6. TABLE 5 MINIMALLY INVASIVE VASECTOMY FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      7. TABLE 6 GLOBAL VASECTOMY MARKET, BY DRUGS, 2023-2030 (USD MILLION)
      8. TABLE 7 ANESTHETICS FOR VASECTOMY MARKET, BY REGION, 2023-2030 (USD MILLION)
      9. TABLE 8 PAIN KILLERS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      10. TABLE 9 ANTIBIOTICS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      11. TABLE 10 OTHERS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      12. TABLE 11 GLOBAL VASECTOMY MARKET, BY PATIENTS, 2023-2030 (USD MILLION)
      13. TABLE 12 HUMANS FOR VASECTOMY MARKET, BY REGION, 2023-2030 (USD MILLION)
      14. TABLE 13 ANIMALS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      15. TABLE 14 GLOBAL VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      16. TABLE 15 NORTH AMERICA VASECTOMY MARKET, BY COUNTRY 2023-2030 (USD MILLION)
      17. TABLE 16 NORTH AMERICA VASECTOMY MARKET, BY TYPE 2023-2030 (USD MILLION)
      18. TABLE 17 NORTH AMERICA VASECTOMY MARKET, BY DRUGS 2023-2030 (USD MILLION)
      19. TABLE 18 NORTH AMERICA VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
      20. TABLE 19 NORTH AMERICA VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      21. TABLE 20 NORTH AMERICA VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION
      22. TABLE 21 EUROPE VASECTOMY MARKET, BY COUNTRY 2023-2030 (USD MILLION)
      23. TABLE 22 EUROPE VASECTOMY MARKET, BY TYPE 2023-2030 (USD MILLION)
      24. TABLE 23 EUROPE VASECTOMY MARKET, BY DRUGS 2023-2030 (USD MILLION)
      25. TABLE 24 EUROPE VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
      26. TABLE 25 EUROPE VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      27. TABLE 26 EUROPE VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION)
      28. TABLE 27 ASIA PACIFIC VASECTOMY MARKET, BY COUNTRY 2023-2030 (USD MILLION)
      29. TABLE 28 ASIA PACIFIC VASECTOMY MARKET, BY TYPE 2023-2030 (USD MILLION)
      30. TABLE 29 ASIA PACIFIC VASECTOMY MARKET, BY DRUGS 2023-2030 (USD MILLION)
      31. TABLE 30 ASIA PACIFIC VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
      32. TABLE 31 ASIA PACIFIC VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      33. TABLE 32 ASIA PACIFIC VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION
      34. TABLE 33 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY COUNTRY 2023-2030 (USD MILLION)
      35. TABLE 34 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY TYPE 2023-2030 (USD MILLION)
      36. TABLE 35 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY DRUGS 2023-2030 (USD MILLION)
      37. TABLE 36 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
      38. TABLE 37 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      39. TABLE 38 MIDDLE EAST & AFRICA VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION List Of Figures
      40. FIGURE 1 RESEARCH PROCESS
      41. FIGURE 2 MARKET DYNAMICS FOR GLOBAL VASECTOMY MARKET
      42. FIGURE 3 GLOBAL VASECTOMY MAKRET, BY SEGMENT, 2023
      43. FIGURE 4 GLOBAL VASECTOMY SUCCESS MARKET, BY REGION
      44. FIGURE 5 GLOBAL VASECTOMY MARKET SHARE, BY TYPE 2023
      45. FIGURE 6 GLOBAL VASECTOMY MARKET SHARE, BY SYSTEM 2023
      46. FIGURE 7 GLOBAL VASECTOMY MARKET SHARE, BY PATIENTS 2023
      47. FIGURE 8 GLOBAL VASECTOMY MARKET SHARE, BY END USER, 2023
      48. FIGURE 9 GLOBAL VASECTOMY MARKET SHARE, 2023
      49. FIGURE 10 GLOBAL VASECTOMY MARKET SHARE, BY REGION, 2023
      50. FIGURE 11 NORTH AMERICA VASECTOMY MARKET SHARE, BY COUNTRY, 2023
      51. FIGURE 12 EUROPE VASECTOMY MARKET SHARE, BY COUNTRY, 2023
      52. FIGURE 13 ASIA PACIFIC VASECTOMY MARKET SHARE, BY COUNTRY, 2023
      53. FIGURE 14 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY REGION, 2023
      54. FIGURE 15 GLOBAL VASECTOMY MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
      55. FIGURE 16 ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.: KEY FINANCIALS
      56. FIGURE 17 ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.: SEGMENTAL REVENUE
      57. FIGURE 18 ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.: GEOGRAPHICAL REVENUE
      58. FIGURE 19 PFIZER, INC.: KEY FINANCIALS
      59. FIGURE 20 PFIZER, INC.: SEGMENTAL REVENUE
      60. FIGURE 21 PFIZER, INC.: GEOGRAPHICAL REVENUE
      61. FIGURE 22 ADVANCED MEDITECH INTERNATIONAL: KEY FINANCIALS
      62. FIGURE 23 ADVANCED MEDITECH INTERNATIONAL: SEGMENTAL REVENUE
      63. FIGURE 24 ADVANCED MEDITECH INTERNATIONAL: GEOGRAPHICAL REVENUE
      64. FIGURE 25 ABBOTT: KEY FINANCIALS
      65. FIGURE 26 ABBOTT: SEGMENTAL REVENUE
      66. FIGURE 27 ABBOTT: GEOGRAPHICAL REVENUE
      67. FIGURE 28 SKLAR SURGICAL INSTRUMENTS: FINANCIAL REVENUE
      68. FIGURE 29 SKLAR SURGICAL INSTRUMENTS: SEGMENTAL REVENUE
      69. FIGURE 30 SKLAR SURGICAL INSTRUMENTS: GEOGRPAHICAL REVENUE

    Vasectomy Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials